3

PRIMARY DOCUMENT

Company: LEXICON PHARMACEUTICALS, INC.
Filed: October 1, 2021
Period of Report: October 1, 2021
Accession Number: 0001127602-21-026256

View Document ↗ View on SEC.gov ↗